Cargando…
Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon
Breast cancer is the most prevalent malignancy in women in Western countries, currently accounting for one third of all female cancers. Familial aggregation is thought to account for 5–10 % of all BC cases, and germline mutations in BRCA1 and BRCA2 account for less of the half of these inherited cas...
Autores principales: | Jalkh, Nadine, Nassar-Slaba, Jinane, Chouery, Eliane, Salem, Nabiha, Uhrchammer, Nancy, Golmard, Lisa, Stoppa-Lyonnet, Domique, Bignon, Yves-Jean, Mégarbané, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441239/ https://www.ncbi.nlm.nih.gov/pubmed/22713736 http://dx.doi.org/10.1186/1897-4287-10-7 |
Ejemplares similares
-
1Novel MEFV transcripts in Familial Mediterranean fever patients and controls
por: Medlej-Hashim, Myrna, et al.
Publicado: (2010) -
Next-generation sequencing in familial breast cancer patients from Lebanon
por: Jalkh, Nadine, et al.
Publicado: (2017) -
The biological effects and clinical implications of BRCA mutations: where do we go from here?
por: Stoppa-Lyonnet, Dominique
Publicado: (2016) -
Contribution of copy number variants (CNVs) to congenital, unexplained intellectual and developmental disabilities in Lebanese patients
por: Choucair, Nancy, et al.
Publicado: (2015) -
CHEK2 contribution to hereditary breast cancer in non-BRCA families
por: Desrichard, Alexis, et al.
Publicado: (2011)